Comparison of Remimazolam-Flumazenil versus Propofol for Rigid Bronchoscopy: A Prospective Randomized Controlled Trial
- PMID: 36615057
- PMCID: PMC9821250
- DOI: 10.3390/jcm12010257
Comparison of Remimazolam-Flumazenil versus Propofol for Rigid Bronchoscopy: A Prospective Randomized Controlled Trial
Abstract
Background: Remimazolam is a novel ultrashort-acting intravenous benzodiazepine sedative−hypnotic that significantly reduces the times to sedation onset and recovery. This trial was conducted to confirm the recovery time from anesthesia of remimazolam-flumazenil versus propofol in patients undergoing endotracheal surgery under rigid bronchoscopy. Methods: Patients undergoing endotracheal tumor resection or stent implantation were randomly allocated into a remimazolam group (Group R) or a propofol group (Group P). The primary outcome was the recovery time from general anesthesia. The secondary outcomes were the time to loss of consciousness (LoC), hemodynamic fluctuations, and adverse events. Results: A total of 34 patients were screened, and 30 patients were enrolled in the study. The recovery time was significantly shorter for Group R (140 ± 52 s) than for Group P (374 ± 195 s) (p < 0.001). The times to LoC were 76 ± 40 s in Group R and 75 ± 25 s in Group P and were not significantly different. There were also no significant differences in hemodynamic fluctuations or adverse events between the two groups. Conclusions: The recovery time from general anesthesia in rigid bronchoscopy patients was shorter using remimazolam-flumazenil than with propofol, with no dramatic hemodynamic fluctuations and adverse events or differences between the agents. Remimazolam-flumazenil allows for faster recovery from anesthesia than propofol.
Keywords: flumazenil; hemodynamic fluctuations; loss of consciousness; propofol; recovery time from anesthesia; remimazolam; rigid bronchoscopy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Comparison of recovery profiles between total intravenous anaesthesia with propofol or remimazolam reversed with flumazenil in patients undergoing breast surgery: A randomised controlled trial.Eur J Anaesthesiol. 2024 Mar 1;41(3):199-207. doi: 10.1097/EJA.0000000000001951. Epub 2024 Jan 11. Eur J Anaesthesiol. 2024. PMID: 38205822 Clinical Trial.
-
Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: A randomized controlled trial.Medicine (Baltimore). 2023 Nov 17;102(46):e36081. doi: 10.1097/MD.0000000000036081. Medicine (Baltimore). 2023. PMID: 37986333 Free PMC article. Clinical Trial.
-
Comparison of Remimazolam Tosilate and Propofol Sedation on the Early Postoperative Quality of Recovery in Patients Undergoing Day Surgery: A Prospective Randomized Controlled Trial.Drug Des Devel Ther. 2024 May 23;18:1743-1754. doi: 10.2147/DDDT.S456675. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38803562 Free PMC article. Clinical Trial.
-
Hemodynamic Influences of Remimazolam Versus Propofol During the Induction Period of General Anesthesia: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Pain Physician. 2023 Nov;26(7):E761-E773. Pain Physician. 2023. PMID: 37976477
-
Comparison of Remimazolam-Flumazenil versus Propofol for Recovery from General Anesthesia: A Systematic Review and Meta-Analysis.J Clin Med. 2023 Nov 26;12(23):7316. doi: 10.3390/jcm12237316. J Clin Med. 2023. PMID: 38068368 Free PMC article. Review.
Cited by
-
Effect of converting from propofol to remimazolam with flumazenil reversal on recovery from anesthesia in outpatients with mental disabilities: a randomized controlled trial.BMC Anesthesiol. 2024 Apr 22;24(1):151. doi: 10.1186/s12871-024-02526-5. BMC Anesthesiol. 2024. PMID: 38649838 Free PMC article. Clinical Trial.
-
Anesthesia for Bronchoscopy-An Update.J Clin Med. 2024 Oct 29;13(21):6471. doi: 10.3390/jcm13216471. J Clin Med. 2024. PMID: 39518611 Free PMC article. Review.
-
Effectiveness of perioperative remimazolam in preventing postoperative delirium: a systematic review and meta-analysis.Eur J Med Res. 2025 Feb 21;30(1):122. doi: 10.1186/s40001-025-02383-z. Eur J Med Res. 2025. PMID: 39985104 Free PMC article.
-
Remimazolam and Its Place in the Current Landscape of Procedural Sedation and General Anesthesia.J Clin Med. 2024 Jul 25;13(15):4362. doi: 10.3390/jcm13154362. J Clin Med. 2024. PMID: 39124629 Free PMC article. Review.
-
Effects of Remimazolam Anesthesia with Two Induction Doses on Hemodynamics and Recovery Profile in Older Patients: Comparison with Propofol Anesthesia.J Clin Med. 2023 Aug 14;12(16):5285. doi: 10.3390/jcm12165285. J Clin Med. 2023. PMID: 37629327 Free PMC article.
References
-
- Antonik L.J., Goldwater D.R., Kilpatrick G.J., Tilbrook G.S., Borkett K.M. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics. Anesth. Analg. 2012;115:274–283. doi: 10.1213/ANE.0b013e31823f0c28. - DOI - PubMed
-
- Mao Y., Guo J., Yuan J., Zhao E., Yang J. Quality of Recovery After General Anesthesia with Remimazolam in Patients’ Undergoing Urologic Surgery: A Randomized Controlled Trial Comparing Remimazolam with Propofol. Drug Des. Dev. Ther. 2022;16:1199–1209. doi: 10.2147/DDDT.S359496. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources